Cholesterol Testing Services Market Analysis

Cholesterol Testing Services Market Analysis

To get key market trends

  Download Free Sample

Based on test type, the market is segmented into total cholesterol tests, high density lipoprotein (HDL) cholesterol tests, low density lipoprotein (LDL) cholesterol tests, triglyceride tests, and other tests. The total cholesterol tests segment is exceeded USD 14.4 billion by 2032.
 

• Total cholesterol tests provide a comprehensive measure of the total amount of cholesterol present in the blood, including both low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and other lipoproteins. This single test gives healthcare providers an overall picture of a patient's lipid profile and is valuable for assessing cardiovascular risk and guiding treatment decisions.
   
• The test has been a cornerstone of cardiovascular risk assessment for decades. It is a widely accepted and standardized test used in routine health screenings, preventive care, and disease management. Healthcare providers rely on total cholesterol levels as an essential component of lipid profiling and cardiovascular risk stratification in patients.
   
• Furthermore, these tests are relatively simple and easy to perform, requiring a single blood sample and standardized laboratory assays. They can be integrated into routine health check-ups, wellness programs, and population-based screening initiatives without the need for specialized equipment or expertise. This simplicity and convenience contribute to the widespread adoption of total cholesterol testing in clinical practice.
   
• Elevated total cholesterol levels, particularly when accompanied by abnormal levels of LDL cholesterol and other lipid fractions, indicate an increased risk of atherosclerosis, heart disease, and stroke. Consequently, total cholesterol testing helps healthcare providers identify individuals who may benefit from further evaluation, lifestyle modifications, or pharmacological interventions to reduce cardiovascular risk, thereby accelerating the segmental growth.
   

Based on product type, the cholesterol testing services market is divided into testing kits, testing strips, and other product types. The testing kits segment was valued at USD 9.2 billion in 2023.

• Testing kits offer convenience by allowing individuals to test their cholesterol levels from the comfort of their own homes. This convenience eliminates the need for a visit to a healthcare facility, saving time and effort for users.
   
• Increase in cholesterol screening further escalated the adoption of these kits. For instance, according to the National Institutes of Health, 2023, there has more than 10% increased in the cholesterol screening rates in the last decade.
   
• Further, testing kits are widely available for purchase online, over the counter at pharmacies, and in retail stores. This accessibility makes it easy for individuals to obtain testing kits without the need for a prescription or a healthcare provider's visit.
   
• Testing kits typically provide rapid results, allowing individuals to obtain their cholesterol measurements quickly, sometimes within minutes. This rapid turnaround time enables users to take immediate action based on their cholesterol levels and make informed decisions about their diet, lifestyle, and healthcare management.
   
• Thus, such aforementioned factors are expected to augment the segmental growth.
   

Based on application, the cholesterol testing services market is divided into cardiovascular diseases, diabetes, obesity, hyperlipidemia, and other applications. Cardiovascular diseases segment accounted for a market share of 33.4% in 2023.
 

• Cardiovascular diseases, including heart disease and stroke, are leading causes of morbidity and mortality worldwide. High cholesterol levels are a major risk factor for the development of CVDs. As a result, there is a significant demand for cholesterol testing services among individuals at risk of or already diagnosed with cardiovascular diseases.
   
• For instance, according to the Heart Foundation, in 2024, cardiovascular disease accounts for one in four of all deaths, claiming the life of one person every 12 minutes.
   
• Further, according to the latest report of European Commission, in 2024, cardiovascular diseases are the leading cause of death in the EU, mainly concerning heart attacks and strokes.
   
• The global population is aging leading to an increase in the prevalence of cardiovascular diseases. Older adults are more likely to have elevated cholesterol levels and other risk factors for heart disease, driving demand for cholesterol testing services in this demographic group.
   

Based on age group, the cholesterol testing services market is segmented into geriatric, adult, and pediatric. The geriatric segment held a market size of USD 9.6 in the year 2023.
 

• Cholesterol levels tend to change with age with older adults often experiencing higher levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" cholesterol. Additionally, age-related changes in metabolism, hormonal balance, and lifestyle factors can contribute to dyslipidemia (abnormal lipid levels) and an increased risk of CVDs, necessitating regular cholesterol testing in geriatric individuals.
   
• Increasing geriatric population is also a contributing factor. With more people living with these disorders there’s a substantial pool of the proper management and testing services.
   
• For instance, according to the United Nations, in 2019, 8.5% of people worldwide (617 million) were aged 65 and over. By 2050, this is projected to nearly double to 16% of the global population.
   
• Further, healthcare organizations and professional societies, such as the American Heart Association (AHA) and the American College of Cardiology (ACC), recommend routine cholesterol screening for older adults as part of cardiovascular risk assessment and preventive care. Thus, escalating the growth of the market.
   

Based on service provider, the cholesterol testing services market is segmented into hospitals and clinics, diagnostic laboratories, ambulatory care centers, and other service providers. The hospitals and clinics segment is expected to reach USD 15.9 by 2032.
 

• Hospitals and clinics are comprehensive healthcare facilities equipped with a wide range of medical services, including diagnostic testing capabilities. They often have well-established laboratory facilities equipped with advanced cholesterol testing equipment and trained personnel to perform cholesterol tests efficiently and accurately.
   
• They typically serve a large volume of patients, including individuals seeking routine health check-ups, preventive screenings, and management of chronic conditions such as cardiovascular disease.
   
• Further, cholesterol testing is a routine part of health assessments and cardiovascular risk assessments conducted in hospitals and clinics, contributing to a high volume of cholesterol tests performed in these settings.
   
• Hospitals often house specialized departments or units focused on cardiology, internal medicine, endocrinology, and other medical specialties that manage patients with cardiovascular risk factors, including high cholesterol levels. Patients seeking specialized care for cholesterol management are more likely to undergo cholesterol testing in hospitals and clinics where they can access comprehensive medical services and expertise.
   

The U.S. cholesterol testing services market is anticipated to grow at CAGR of 7.8% during 2024 to 2032.
 

• Cardiovascular disease (CVD remains a leading cause of morbidity and mortality in the U.S. High cholesterol levels are a major risk factor for CVD, leading to a high demand for cholesterol testing services among the population.
   
• For instance, according to the National Institutes of Health, in 2022, CVD accounted for 928,741 deaths in the U.S., with coronary heart disease (CHD) being the leading cause of CVD-related deaths at 41.2%, followed by stroke at 17.3%.
   

Germany cholesterol testing services market is anticipated to witness lucrative growth between 2024 – 2032.
 

• The country has a universal healthcare system that provides comprehensive health coverage to its residents through statutory health insurance (SHI) funds or private health insurance (PHI) companies.
   
• Cholesterol testing services are typically covered by health insurance plans, ensuring widespread access and affordability for patients seeking preventive screenings or diagnostic evaluations.
   

Japan cholesterol testing services market is expected to grow significantly over the years.
 

• Japan places a strong emphasis on preventive medicine and public health initiatives aimed at reducing the burden of chronic diseases and promoting healthy aging. Regular cholesterol screening is recommended as part of routine health check-ups, particularly for middle-aged and older adults, to identify individuals at risk of cardiovascular disease and initiate appropriate interventions.
   
• Further, the country is known for its technological innovation and contributions to medical research and healthcare delivery. The country's healthcare industry invests in advanced diagnostic technologies, laboratory equipment, and assay platforms for cholesterol testing, ensuring accurate, reliable, and efficient test results for patients and healthcare providers.
   

UAE cholesterol testing services market is anticipated to witness lucrative growth between 2024 – 2032.
 

• UAE is at the forefront of technological innovation in healthcare, with investments in digital health solutions, telemedicine platforms, and advanced diagnostic technologies.
   
• Cholesterol testing services benefit from technological advancements such as point-of-care testing devices, automated laboratory analyzers, and digital health platforms, which enhance the accuracy, efficiency, and accessibility of testing services.